2023 PTAB Year in Review: Analysis & Trends: 2023 Changes in Director Review | Sterne, Kessler, Goldstein & Fox P.L.L.C.

On July 24, 2023, the United States Patent and Trademark Office (USPTO or Office) promulgated a revised interim process for Director Review of Patent Trial and Appeal Board (PTAB or...

Related Keywords

United States ,Hangzhou ,Zhejiang ,China ,Delaware ,America ,Goldstein Fox ,Thomas Kraus ,United States Court ,Dk Crown Holdings Inc ,A Party ,Resmed Corp ,United States District Court ,Supreme Court ,Trademark Office ,Advisory Committee ,Appeals Review Panel ,Precedential Opinion Panel ,How Doesa Party ,Us Court ,Rehearing Panel ,Dk Crown Holdings ,Arthrex Inc ,Biotech Co Ltd ,United States Patent ,Director Review ,Patent Trial ,Appeal Board ,America Invents Act ,Administrative Patent Judge ,Executive Branch ,Decisions Can Be Reviewed Under ,New Interim ,Although Arthrex ,Party Request Director Review ,Federal Circuit ,Director Review Request ,Happens After ,Party Request Director ,Delegated Review Panel ,Chief Judge ,Deputy Chief Judge ,Vice Chief Judges ,Senior Lead ,Director Entertain Amicus ,Federal Rule ,Appellate Procedure ,Director Granted Requests ,Review Under ,Patent Owner ,Their Uses ,Cell Binding ,Delegated Review ,Medical Devices Ind ,Judge Williams ,Judge William ,Interim Director Review Process ,